Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850. https://doi.org/10.1001/jama.2013.280319

Article  CAS  PubMed  Google Scholar 

Lah TT, Novak M, Breznik B (2020) Brain malignancies: Glioblastoma and brain metastases. Semin Cancer Biol 60:262–273. https://doi.org/10.1016/j.semcancer.2019.10.010

Article  CAS  PubMed  Google Scholar 

Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wissmann N, Botz M, Soyka SJ, Beretta CA, Pramatarov RL, Fankhauser L, Garofano L, Freudenberg A, Wagner J, Tanev DI, Ratliff M, Xie R, Kessler T, Hoffmann DC, Hai L, Dorflinger Y, Hoppe S, Yabo YA, Golebiewska A, Niclou SP, Sahm F, Lasorella A, Slowik M, Doring L, Iavarone A, Wick W, Kuner T, Winkler F (2022) Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell 185:2899–2917e2831. https://doi.org/10.1016/j.cell.2022.06.054

Article  CAS  PubMed  Google Scholar 

Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M (2019) Molecular targeted therapy of glioblastoma. Cancer Treat Rev 80:101896. https://doi.org/10.1016/j.ctrv.2019.101896

Article  CAS  PubMed  Google Scholar 

Campos B, Olsen LR, Urup T, Poulsen HS (2016) A comprehensive profile of recurrent glioblastoma. Oncogene 35:5819–5825. https://doi.org/10.1038/onc.2016.85

Article  CAS  PubMed  Google Scholar 

Ma R, Taphoorn MJB, Plaha P (2021) Advances in the management of glioblastoma. J Neurol Neurosurg Psychiatry 92:1103–1111. https://doi.org/10.1136/jnnp-2020-325334

Article  PubMed  Google Scholar 

Hernandez A, Domenech M, Munoz-Marmol AM, Carrato C, Balana C (2021) Glioblastoma: relationship between metabolism and immunosuppressive microenvironment. Cells 10:3529. https://doi.org/10.3390/cells10123529

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nduom EK, Weller M, Heimberger AB (2015) Immunosuppressive mechanisms in glioblastoma. Neuro Oncol 17 Suppl 7:vii9–vii14. https://doi.org/10.1093/neuonc/nov151

Article  CAS  Google Scholar 

Cui X, Morales RT, Qian W, Wang H, Gagner JP, Dolgalev I, Placantonakis D, Zagzag D, Cimmino L, Snuderl M, Lam RHW, Chen W (2018) Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials 161:164–178. https://doi.org/10.1016/j.biomaterials.2018.01.053

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desland FA, Hormigo A (2020) The CNS and the brain tumor microenvironment: implications for glioblastoma immunotherapy. Int J Mol Sci 21:7358. https://doi.org/10.3390/ijms21197358

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M (2020) Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release 317:273–281. https://doi.org/10.1016/j.jconrel.2019.11.009

Article  CAS  PubMed  Google Scholar 

Liu X, Cao Z, Liu N, Gao G, Du M, Wang Y, Cheng B, Zhu M, Jia B, Pan L, Zhang W, Jiang Y, He W, Xu L, Zhang W, An Q, Guo Q, Gu J (2022) Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma. Front Pharmacol 13:975291. https://doi.org/10.3389/fphar.2022.975291

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zhai M, Chen Z, Han X, Yu F, Li Z, Xie X, Han C, Yu L, Yang Y, Mei X (2017) Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma. Drug Deliv 24:1045–1055. https://doi.org/10.1080/10717544.2017.1344334

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou W, Zhou Y, Chen X, Ning T, Chen H, Guo Q, Zhang Y, Liu P, Zhang Y, Li C, Chu Y, Sun T, Jiang C (2021) Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials 268:120546. https://doi.org/10.1016/j.biomaterials.2020.120546

Article  CAS  PubMed  Google Scholar 

Yuan F, Ming H, Wang Y, Yang Y, Yi L, Li T, Ma H, Tong L, Zhang L, Liu P, Li J, Lin Y, Yu S, Ren B, Yang X (2020) Molecular and clinical characterization of Galectin-9 in glioma through 1,027 samples. J Cell Physiol 235:4326–4334. https://doi.org/10.1002/jcp.29309

Article  CAS  PubMed  Google Scholar 

Zhang F, Parayath NN, Ene CI, Stephan SB, Koehne AL, Coon ME, Holland EC, Stephan MT (2019) Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat Commun 10:3974. https://doi.org/10.1038/s41467-019-11911-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Panda SK, Facchinetti V, Voynova E, Hanabuchi S, Karnell JL, Hanna RN, Kolbeck R, Sanjuan MA, Ettinger R, Liu YJ (2018) Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest 128:1873–1887. https://doi.org/10.1172/JCI97333

Article  PubMed  PubMed Central  Google Scholar 

Han Z, Liu S, Lin H, Trivett AL, Hannifin S, Yang, Oppenheim JJ (2019) Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses. Cancer Immunol Immunother 68:1073–1085. https://doi.org/10.1007/s00262-019-02338-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stathopoulos A, Pretto C, Devillers L, Pierre D, Hofman FM, Kruse C, Jadus M, Chen TC, Schijns VE (2012) Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic toll-like receptor 7/8 activation. Oncoimmunology 1:298–305. https://doi.org/10.4161/onci.19068

Article  PubMed  PubMed Central  Google Scholar 

Fu B, Zhao M, Wang L, Patil G, Smith JA, Juncadella IJ, Zuvela-Jelaska L, Dorf ME, Li S (2017) RNAi screen and proteomics reveal NXF1 as a novel regulator of IRF5 signaling. Sci Rep 7:2683. https://doi.org/10.1038/s41598-017-02857-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biray Avci C, Kurt CC, Tepedelen BE, Ozalp O, Goker B, Mutlu Z, Dodurga Y, Elmas L, Gunduz C (2016) Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells. Tumour Biol 37:6673–6679. https://doi.org/10.1007/s13277-015-4519-3

Article  CAS  PubMed  Google Scholar 

Zhou J, Li X, Wu X, Zhang T, Zhu Q, Wang X, Wang H, Wang K, Lin Y, Wang X (2018) Exosomes released from tumor-associated macrophages transfer miRNAs that induce a Treg/Th17 cell imbalance in epithelial ovarian cancer. Cancer Immunol Res 6:1578–1592. https://doi.org/10.1158/2326-6066.CIR-17-0479

Article  CAS  PubMed  Google Scholar 

Kooijmans SAA, Stremersch S, Braeckmans K, de Smedt SC, Hendrix A, Wood MJA, Schiffelers RM, Raemdonck K, Vader P (2013) Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release 172:229–238. https://doi.org/10.1016/j.jconrel.2013.08.014

Article  CAS  PubMed  Google Scholar 

Li HY, He HC, Song JF, Du YF, Guan M, Wu CY (2020) Bone marrow-derived mesenchymal stem cells repair severe acute pancreatitis by secreting miR-181a-5p to target PTEN/Akt/TGF-beta1 signaling. Cell Signal 66:109436. https://doi.org/10.1016/j.cellsig.2019.109436

Article  CAS  PubMed  Google Scholar 

Wang M, Cai Y, Peng Y, Xu B, Hui W, Jiang Y (2020) Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity. Cell Death Dis 11:896. https://doi.org/10.1038/s41419-020-03042-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fabie A, Mai LT, Dagenais-Lussier X, Hammami A, van Grevenynghe J, Stager S (2018) IRF-5 promotes cell death in CD4 T cells during chronic infection. Cell Rep 24:1163–1175. https://doi.org/10.1016/j.celrep.2018.06.107

Article  CAS  PubMed  Google Scholar 

Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, Owens GK, Upchurch GR Jr, Ailawadi G (2013) Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 33:294–304. https://doi.org/10.1161/ATVBAHA.112.300432

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong W, MacTaggart J, Knispel R, Worth J, Persidsky Y, Baxter BT (2009) Blocking TNF-alpha attenuates aneurysm formation in a murine model. J Immunol 183:2741–2746. https://doi.org/10.4049/jimmunol.0803164

Article  CAS  PubMed  Google Scholar 

Batra R, Suh MK, Carson JS, Dale MA, Meisinger TM, Fitzgerald M, Opperman PJ, Luo J, Pipinos II, Xiong W, Baxter BT (2018) IL-1beta (Interleukin-1beta) and TNF-alpha (tumor necrosis Factor-alpha) impact abdominal aortic aneurysm formation by differential effects on macrophage polarization. Arterioscler Thromb Vasc Biol 38:457–463. https://doi.org/10.1161/ATVBAHA.117.310333

Article  CAS  PubMed  Google Scholar 

Hume DA (2006) The mononuclear phagocyte system. Curr Opin Immunol 18:49–53. https://doi.org/10.1016/j.coi.2005.11.008

Article  CAS  PubMed  Google Scholar 

McKenzie MD, Dudek NL, Mariana L, Chong MM, Trapani JA, Kay TW, Thomas HE (2006) Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL. Int Immunol 18:837–846. https://doi.org/10.1093/intimm/dxl020

Article  CAS  PubMed  Google Scholar 

Kalia V, Sarkar S (2018) Regulation of effector and memory CD8 T cell differentiation by IL-2-A balancing act. Front Immunol 9:2987. https://doi.org/10.3389/fimmu.2018.02987

Article